US Seeks Funds for New Bioweapons Projects From Clinton, Soros, Rockefeller Foundations: Russian MoD
©Sputnik/Mikhail Voskresenskiy
Russia's Radiological, Chemical and Biological Defense (RCBD) Troops began extensive reporting on Pentagon funding for military-related biological research in Eastern Europe and around the world in early 2022, with much of their findings based on the thousands of documents seized through the course of the special military operation in Ukraine.
The United States government is actively searching for new sources of funding for military biological projects from leading American 'philanthropic' institutions, including the Clinton, Soros, Rockefeller and Biden Foundations, RCBD Troops chief Igor Kirillov has announced.
"Based on an analysis of documents received in the course of the special military operation, the structure of the system created by the US administration for the global management of biological risks has become clear," Kirillov said in a briefing Monday, summarizing an analysis of US military-biological activities in Ukraine and other countries over the course of 2023.
"It consists of government agencies and private contractors, including representatives of Big Pharma. Through the organs of the executive branch, a legislative framework is being created to finance military-biological research directly from the federal budget. Guarantees provided by the state attract funds from non-governmental organizations controlled by the Democratic Party leadership, including the Clinton, Rockefeller, Soros and Biden Foundations," Kirillov said.
According to the RCBD Troops' chief's information, the main private contractors involved in the Pentagon's military-biological program include Metabiota, Black & Veatch and CH2M, with the companies tasked with the construction of facilities and the supply of equipment to labs around the globe. Their work is coordinated by the DoD's Defense Threat Reduction Agency.
Washington's goals are multifold, Kirillov said, and include the study of the causative agents of "particularly dangerous infections in regions of the world that are strategically important for the United States," and achieving "superiority" in biomanufacturing, including by using biological espionage against potential geopolitical adversaries.
"Materials received have confirmed that the US military was set the task of monitoring the biological situation in the Middle East and Central Asia, territories bordering China, Turkiye, Pakistan and Saudi Arabia," Kirillov said. "Over the past year, the Pentagon developed and adopted a number of conceptual documents involving the expansion of the foreign network of US-controlled biological laboratories, and continuing military biological research beyond America's national jurisdiction."
Furthermore, the RCBD Troops chief said, 2023 saw the creation of new administrative and technical structures, including the Office of Pandemic Preparedness and Response Policy, and the State Department's new Bureau of Global Health Security and Diplomacy, with their main aims presumed to be centered on securing the further expansion of America's military-biological activities worldwide.
"While the stated goals include 'monitoring infectious diseases' and providing assistance to developing countries, the example of Ukraine makes clear how the military-biological potential of the United States is being built up," using otherwise seemingly benign institutions, Kirillov said.
The RCBD Troops commander pointed out, for instance, that by the time Russia kicked off its military operation in Ukraine, the Pentagon was already deeply engaged in a series of dangerous experiments studying the causative agents of dangerous diseases, including tularemia, anthrax and hantavirus, monitoring the local biological environment, collecting virus strains and studying the susceptibility of the local population to various diseases (including via unethical and potentially illegal experiments against an unwitting civilian population, ed.).
Washington's European allies engaged in similar projects throughout 2023, promoting the creation of a network of 'Chemical, Biological, Radiological and Nuclear Risk Mitigation Centers of Excellence', which Kirillov said are factually aimed at placing biolabs in former Soviet republic countries. The Ukrainian case has shed light on how such institutions are financed via a series of grants to the country's Science and Technology Center, with similar projects popping up in Central Asian countries and the Southern Caucasus
Citing one example of military-biological activities by NATO countries in the former Soviet space, Kirillov pointed to 'Project 2410' - research conducted with the participation of researchers from the University of Florida studying natural resistance of the causative agent of the brucellosis virus in domesticated and wild animals, including its possible transmission to human beings.
Another project, known as 'Project 2513' deals with risk factors and resistance of virulent enterobacteriaceae, including "isolating strains which are resistant to all known classes of antibiotics."
"Project 2545 involves modeling the evolutionary changes of individual viruses which are highly pathogenic to humans. The research was supported by the UK Research and Innovation agency," Kirillov said.
As before, the RCBD Troops chief said, US military-biological research abroad in 2023 was designed to take advantage of gaps in international legislation, allowing researchers to engage in highly risky research abroad which they would be prohibited from doing at home.
"The fact that the United States is blocking any international initiatives to verify the Biological Weapons Convention is of particular concern. This excludes the possibility of checking the activities of laboratories both in the United States and abroad," Kirillov said, pointing to US efforts to block or ignore Russian questions about the potential violations of the Convention by Kiev and Washington, including as relates to "research carried out on Ukrainian military personnel and the mentally ill, and the concealment by Ukraine and the United States of evidence of cooperation in the military-biological field in international reporting."
Kirillov also pointed efforts to reduce the potential political fallout from the revelations by Russia related to US military-biological activities, including via pressure against both allies and developing countries, to prevent the Russian RCBD Troops' findings from being discussed at the UN Security Council, and at the Organization for the Prohibition of Chemical Weapons.
"We have said repeatedly that the work of American military biologists is aimed at the creation of 'artificially controlled epidemics', and that it is not controlled within the framework of the Biological Weapons Convention nor the UN Secretary-General's mechanism for investigating the use of biological weapons," Kirillov said.
In light of these activities, the RCBD Troops chief expressed concerns about the potential for the "further deterioration" of the global epidemiological situation, including via the creation of new "artificial foci of diseases and an uncontrolled expansion" of disease carriers. The identification of Asian and African disease-carrying mosquitos in European countries, an increase in the incidence of atypical infections across the region, from dengue to West Nile virus, are all evidence of this deteriorating situation, Kirillov said.
